Jay D Martin, Chief Financial Officer, on May 29, 2026, sold 2,907 shares in Credit Acceptance (CACC) for $1,675,251. Following the Form 4 filing with the SEC, Martin has control over a total of 25,963 common shares of the company, with 25,963 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/885550/000088555026000114/xslF345X05/wk-form4_1780430651.xml
Carmen Bozic, Executive Vice President and Chief Medical Officer, on May 29, 2026, sold 1,974 shares in Vertex Pharmaceuticals (VRTX) for $888,300. Following the Form 4 filing with the SEC, Bozic has control over a total of 22,760 common shares of the company, with 22,760 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/875320/000087532026000228/xslF345X05/wk-form4_1780430661.xml
LeAnn B Smith, Executive Vice President & Chief Human Resources Officer, on June 01, 2026, sold 1,810 shares in Mckesson (MCK) for $1,331,255. Following the Form 4 filing with the SEC, Smith has control over a total of 4,798 common shares of the company, with 4,798 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/927653/000092765326000136/xslF345X05/form4.xmlPrice: $734.24, Change: $-0.59, Percent Change: -0.08%
David Philip Henry, Executive Vice President, Global Strategic Marketing and General Manager, Materials Solutions Division, on June 01, 2026, sold 6,000 shares in MKS (MKSI) for $1,886,583. Following the Form 4 filing with the SEC, Henry has control over a total of 10,422 common shares of the company, with 10,422 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1049502/000104950226000100/xslF345X05/form4.xmlPrice: $330.53, Change: $+12.91, Percent Change: +4.06%